1 This insulin secretion causes an overall decrease in blood sugar levels, reduces the production of glucagon, which prevents the release of glucose storage from the liver, and induces a satiety response that elevates insulin sensitivity and causes weight loss
Your clinician can guide you on managing this interaction
Trulicity is not approved for use by anyone younger than 10 years old with type 2 diabetes
GLP-1 drugs commonly cause gastrointestinal symptoms
This partial reversal may be driven by factors such as compliance challenges, waning drug efficacy or measurement limitations
Therefore, to clarify whether the function of GLP-1R is activated or inhibited in CM, we detected the changes in the level of endogenous GLP-1, a natural agonist of GLP-1R, in the TNC in NTG-induced CM mice